Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

MRI: early-phase trial registry

5 of 6 indexed MRI trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count

MRI: 6 US clinical trials tracked, 5 recruiting.

MRI is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Urological Research Network, running 1 of these trials.

Enrollment posture brief

Registry condition mri

OPEN 5 | RECR 83% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)

MRI (this)83%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near MRI

MRI lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for MRI on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. MRI is recruiting above its size-band peers.

    5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates MRI research.

    Urological Research Network accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most MRI trials plan to enrol fewer than 100 people.

    Median target enrolment is 62 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. MRI research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on MRI records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

MRI Imaging Diagnostic test
1 trials
TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT) Device
1 trials
Whey Protein Dietary supplement
1 trials
Alcohol beverage Other
1 trials
Kenetik Dietary supplement
1 trials
MRI Diagnostic test
1 trials
Placebo Dietary supplement
1 trials

US sites by state

Facility locations filed on MRI trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Oregon 1 trials
Maryland 1 trials
Massachusetts 1 trials
Kansas 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this MRI page

6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This MRI condition card totals 6 registered trials; most-linked intervention MRI Imaging; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.